Therapeutic Vaccine Market Growth Propelled by Chronic Illness

The global therapeutic vaccine market valued $19.62 billion in 2018. Furthermore, the market is projected to increase at a CAGR of 36.52% during the forecast period 2019-2025.

Hyderabad, India - September 4, 2019 /MarketersMedia/ —

Rising incidences of various chronic illnesses such as cancer, HIV and cardiovascular diseases, innovative and effective vaccines present in the healthcare industry and increasing governmental funding for vaccine development are some of the factors proliferating the demand of therapeutic vaccine, as per the market research report from IndustryARC. The report has assessed the global therapeutic vaccine market valued $19.62 billion in 2018. Furthermore, the market is projected to increase at a CAGR of 36.52% during the forecast period 2019-2025.

The report is titled “Therapeutic Vaccine Market: By Vaccine Type (Addiction, Neurological, Infectious, and Autoimmune); By Technology (Autologous, Allogenic) and By Region – Forecast (2019-2025).” It consolidates an in-depth analysis of the imperative aspects of the market including market drivers, market value chain, restraints, growth indicators, market trends, challenges, future outlook, and market insights. The report covers therapeutic vaccine market size by type and technology , therapeutic vaccine market share by top 5 companies and also the market share by start-ups during the forecast period.

View Full Table of Contents of Therapeutic Vaccine Market:
https://www.industryarc.com/Report/16292/therapeutic-vaccine-market.html

Report Price (Single User): US $3850

Therapeutic Vaccine Market: Leading Segments

North America constitute a dominant regional share accounted 46% of global market in 2018. Growing initiatives by healthcare centers, improving recommended immunization, rising adoption of advanced technology in healthcare, improved infrastructure and increasing healthcare expenditure are some important factors that have rendered North America with maximum demand share in the therapeutic vaccine market.

Therapeutic vaccine market is segmented on basis of type into addiction vaccines, autoimmune disease vaccines, cancer vaccines, infectious disease vaccines, neurological disease vaccines and Parkinson’s disease vaccines. Among these, autoimmune disease vaccines is found to be the major application segment. As per the recent studies by American Autoimmune Related Diseases Association, autoimmune diseases are affecting nearly 50 million Americans, boosting the usage of autoimmune disease vaccine for treatment.Resultantly, key market players have capitalized on this application segment which is expected to grow with a CAGR of 18% through to 2025.

Therapeutic Vaccine Market Disruptive Trends

Certain number of innovative technologies are being developed in accordance with the development of new vaccines. Some of the latest disruptive trends are listed below:

Single injection systems with self-locking syringe:

It is designed to limit the problem of reutilization of needles. This technology simplifies intradermal injection by using a small needle than a conventional one. Furthermore, patches comprising a set of micro-needles also used for intradermal injection are currently under development. Single injection systems with self-locking syringe technology is dominating the therapeutic vaccine market.

Jet Injector:

As per the studies of Clinical, Cosmetic and Investigational Dermatology (CCID), jet injector is gaining momentum in therapeutic vaccine market. All safety concerns associated with needles are eliminated by jet injectors as vaccines are injected using gas or air pressurized systems.

Nasal Vaccine:

The therapeutic vaccine market has been disrupted by the development of alternate administration routes namely nasal, intranasal, oral, topical, pulmonary, vaginal, and rectal. The nasal route offers the most promising opportunity for vaccine administration. It amplifies safety, convenience and elicit both local and systemic immune responses, therefore providing protection from pathogens while vaccination.

Therapeutic Vaccine Market: Competitive Landscape

Major companies currently holding majority or market share in the global therapeutic vaccine market are themare Cytos Biotechnology AG, Agenus, Inc., Pfizer, Merck & Co., Dendreon Corp., GlaxoSmithKline, Biocon, Argos Therapeutic Inc., Novartis AG and Celtic Pharma.

Talk to one of our sales representative about the full report by providing your details in the link below:
https://www.industryarc.com/support.php?id= 16292

Related Reports:

A. DNA Vaccines Market
https://www.industryarc.com/Report/16032/dna-vaccines-market.html

B. Veterinary Vaccines Market
https://www.industryarc.com/PressRelease/881/Veterinary-Vaccines-Market-Research.html

About IndustryARC:
IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.

Contact Info:
Name: Venkat Reddy
Email: Send Email
Organization: IndustryARC
Phone: (+1) 614-588-8538
Website: https://www.industryarc.com/Domain/8/lifesciences-healthcare-market-research.html

Source URL: https://marketersmedia.com/therapeutic-vaccine-market-growth-propelled-by-chronic-illness/88913946

Source: MarketersMedia

Release ID: 88913946